OsteoAMP / AlloFuse
Bone Grafting
CommercialActive
Key Facts
About Bioventus
Bioventus is a global medical device company with a mission to deliver innovative solutions for active healing, focusing on orthobiologics for pain management and bone repair. Founded in 2012, it has grown through strategic acquisitions to serve over 1.4 million patients annually across 50+ countries. The company is executing a focused strategy, having divested non-core units to concentrate on its higher-growth Pain Treatments, Restorative Therapies, and Surgical Solutions segments.
View full company profileTherapeutic Areas
Other Bone Grafting Drugs
| Drug | Company | Phase |
|---|---|---|
| BioSphere® PUTTY | Synergy Biomedical | Approved |
| DBLogix / CeLLogix | Omnia Medical | Commercial |
| ALLOCYTE® Plus Advanced Viable Bone Matrix | Sanara MedTech | Approved/Commercial |
| ACTIGEN™ Verified Inductive Bone Matrix | Sanara MedTech | Approved/Commercial |